AddThis

Report: Pfizer to sell NYC HQ building

Related Content

No related items were found.

NEW YORK Pfizer is selling one of its New York properties to financial services firm TIAA-CREF, according to published reports.

Bloomberg reported that the drug maker would sell the skyscraper at 685 Third Ave. in New York for between $180 million and $190 million, quoting people familiar with the situation.

The sale reportedly is part of an effort to scale down operations following last year’s acquisition of drug maker Wyeth.

© 2014 Drug Store News. All Rights Reserved.